Search research articles
Contact Us
Filters
Showing results (501-510 of 507) with videos related to
Page
of 51
Sort By:
You have reached the last page of results.
This site can display upto 507 results.
Plos One
|
April 25, 2009
Phase 1/2a study of the malaria vaccine candidate apical membrane antigen-1 (AMA-1) administered in adjuvant system AS01B or AS02A
Michele D Spring, James F Cummings, Christian F Ockenhouse, et al.
Mabs
|
June 7, 2021
A human antibody of potent efficacy against SARS-CoV-2 in rhesus macaques showed strong blocking activity to B.1.351
Chunyin Gu, Xiaodan Cao, Zongda Wang, et al.
Plos One
|
October 18, 2011
Adenovirus-5-vectored P. falciparum vaccine expressing CSP and AMA1. Part B: safety, immunogenicity and protective efficacy of the CSP component
Cindy Tamminga, Martha Sedegah, David Regis, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 20, 2021
The Adjuvanted Recombinant Zoster Vaccine Confers Long-Term Protection Against Herpes Zoster: Interim Results of an Extension Study of the Pivotal Phase 3 Clinical Trials ZOE-50 and ZOE-70
Céline Boutry, Andrew Hastie, Javier Diez-Domingo, et al.
Human Vaccines & Immunotherapeutics
|
November 16, 2012
Clinical trial in healthy malaria-naïve adults to evaluate the safety, tolerability, immunogenicity and efficacy of MuStDO5, a five-gene, sporozoite/hepatic stage Plasmodium falciparum DNA vaccine combined with escalating dose human GM-CSF DNA
Thomas L Richie, Yupin Charoenvit, Ruobing Wang, et al.
Plos One
|
March 5, 2013
DNA prime/Adenovirus boost malaria vaccine encoding P. falciparum CSP and AMA1 induces sterile protection associated with cell-mediated immunity
Ilin Chuang, Martha Sedegah, Susan Cicatelli, et al.
The New England Journal of Medicine
|
April 2, 2015
A Recombinant Vesicular Stomatitis Virus Ebola Vaccine
Jason A Regules, John H Beigel, Kristopher M Paolino, et al.
Page
of 51
Search research articles
Search
Showing results (501-510 of 507) with videos related to
Sort By:
Page
of 51
You have reached the last page of results.
This site can display upto 507 results.
Plos One
|
April 25, 2009
Phase 1/2a study of the malaria vaccine candidate apical membrane antigen-1 (AMA-1) administered in adjuvant system AS01B or AS02A
Michele D Spring, James F Cummings, Christian F Ockenhouse, et al.
Mabs
|
June 7, 2021
A human antibody of potent efficacy against SARS-CoV-2 in rhesus macaques showed strong blocking activity to B.1.351
Chunyin Gu, Xiaodan Cao, Zongda Wang, et al.
Plos One
|
October 18, 2011
Adenovirus-5-vectored P. falciparum vaccine expressing CSP and AMA1. Part B: safety, immunogenicity and protective efficacy of the CSP component
Cindy Tamminga, Martha Sedegah, David Regis, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 20, 2021
The Adjuvanted Recombinant Zoster Vaccine Confers Long-Term Protection Against Herpes Zoster: Interim Results of an Extension Study of the Pivotal Phase 3 Clinical Trials ZOE-50 and ZOE-70
Céline Boutry, Andrew Hastie, Javier Diez-Domingo, et al.
Human Vaccines & Immunotherapeutics
|
November 16, 2012
Clinical trial in healthy malaria-naïve adults to evaluate the safety, tolerability, immunogenicity and efficacy of MuStDO5, a five-gene, sporozoite/hepatic stage Plasmodium falciparum DNA vaccine combined with escalating dose human GM-CSF DNA
Thomas L Richie, Yupin Charoenvit, Ruobing Wang, et al.
Plos One
|
March 5, 2013
DNA prime/Adenovirus boost malaria vaccine encoding P. falciparum CSP and AMA1 induces sterile protection associated with cell-mediated immunity
Ilin Chuang, Martha Sedegah, Susan Cicatelli, et al.
The New England Journal of Medicine
|
April 2, 2015
A Recombinant Vesicular Stomatitis Virus Ebola Vaccine
Jason A Regules, John H Beigel, Kristopher M Paolino, et al.
Page
of 51